A study in participants with obesity or overweight with at least one weight-related comorbidity

Trial Identifier: D8750C00004
Sponsor: AstraZeneca
Start Date: October 2024
Primary Completion Date: August 2025
Study Completion Date: December 2025

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
AU Heidelberg, AU, 3081
AU Maroochydore, AU, 4556
AU Maroubra, AU, 2035
AU Merewether, AU, 2291
CA, ON Sarnia, ON, CA, N7T 4X3
CA, ON Toronto, ON, CA, M3J 0K2
CA, Ontario Hamilton, Ontario, CA, L8L 5G8
CA, Ontario Stouffville, Ontario, CA, L4A1H2
CA, QC Sherbrooke, QC, CA, J1L 0H8
CA, Quebec Montreal, Quebec, CA, H4N 2W2
GB Hull, GB, HU3 2PA
GB Leicester, GB, Le5 4PW
GB Penarth, GB, CF64 2XX
GB Rotherham, GB, S65 1DA
JP Chuo-ku, JP, 103-0027
JP Chuo-ku, JP, 104-0031
JP Shinjuku-ku, JP, 160-0008
JP Suita-shi, JP, 565-0853
US, AL Mobile, AL, US, 36608
US, AZ Phoenix, AZ, US, 85044
US, CA Long Beach, CA, US, 90815
US, FL Hialeah, FL, US, 33012
US, FL Largo, FL, US, 33777
US, FL Orlando, FL, US, 32825
US, FL Tampa, FL, US, 33606
US, GA Woodstock, GA, US, 30189
US, IN Indianapolis, IN, US, 46260
US, MD Lutherville Timonium, MD, US, 21093
US, MO Kansas City, MO, US, 64111
US, MS Gulfport, MS, US, 39503
US, MS Ridgeland, MS, US, 39157
US, NC Statesville, NC, US, 28625
US, NE Omaha, NE, US, 68134
US, NH Portsmouth, NH, US, 03801
US, South Carolina North Charleston, South Carolina, US, 29405
US, TN Knoxville, TN, US, 37938
US, TX Austin, TX, US, 78731
US, TX Dallas, TX, US, 75230
US, TX Port Arthur, TX, US, 77642
US, TX San Antonio, TX, US, 78231
US, TX San Antonio, TX, US, 78249